N

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Director, Total Rewards

Compensation & BenefitsConfirmed live in the last 24 hours
Full-timeBrisbane, CA, USA$250.8k - $278.8k /yr

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 8–10+ years of progressive experience in compensation and benefits, including 3–5 years in a total rewards leadership role.
  • Strong knowledge of equity compensation structures common in biotech, including restricted stock units, incentive stock options, nonqualified stock options, and employee stock purchase plans.
  • Strong analytical skills and the ability to translate complex data into clear insights and recommendations.
  • Sound judgment and discretion in handling sensitive compensation and personnel data.
  • Ability to build programs and processes in a growing, fast-paced environment.
  • Strong communication and stakeholder management skills, including the ability to influence at all organizational levels, including the Board.

Responsibilities

  • Own the design, implementation, and administration of base pay, incentive compensation, equity, and executive compensation programs.
  • Partner with the Chief Human Resources Officer to lead annual compensation cycles, including merit increases, bonus funding and payout, and equity refresh grants.
  • Conduct and manage market benchmarking and job leveling to support competitive and equitable pay practices.
  • Monitor organizational pay equity and lead proactive analyses and remediation.
  • Monitor evolving compensation regulations, including pay transparency and pay equity laws, and ensure practices remain compliant across jurisdictions.
  • Design and manage benefits programs, including health and welfare plans, retirement programs, leave policies, and wellness offerings.
  • Own vendor and broker relationships, lead renewal negotiations, and evaluate new benefits offerings for market competitiveness and fiscal responsibility.
  • Ensure benefits programs comply with ERISA, ACA, ADA, FMLA, COBRA, and other applicable federal and state regulations.
  • Lead open enrollment planning and execution, including employee communication and education strategies.
  • Serve as the subject-matter expert and advisor to the Chief Human Resources Officer, Head of Talent, HR business partners, and people managers on compensation and benefits matters.
  • Partner with Finance on compensation budgeting, forecasting, and equity and stock-plan expense modeling.
  • Partner with Legal on equity plan administration, 409A matters, and regulatory compliance.
  • Develop and deliver communications and training to help managers and employees understand total rewards programs.
  • Partner with the Head of HR Operations to evaluate and implement HRIS and compensation tools and systems to improve efficiency, data integrity, and reporting.

Desired Qualifications

  • An advanced degree or relevant certification such as CCP, CBP, or CEBS is preferred.
  • Prior experience in biotech, pharmaceutical, or life sciences companies is strongly preferred; experience in a clinical-stage or newly commercial company is a plus.

About the Company

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Nurix Therapeutics develops drugs that use the body's own protein-degradation system to treat diseases. Its core approach is to control ubiquitin E3 ligases, enzymes that tag unwanted proteins for breakdown in cells. By modulating these ligases, Nurix aims to create therapeutics, especially small-molecule immuno-oncology agents, that can selectively remove disease-related proteins in cancer and other serious conditions. The company operates by discovering and developing drug candidates and earning revenue through partnerships, licensing, and potential future sales of its medicines. Unlike many biotech firms that target single proteins, Nurix focuses on the protein-degradation pathway to influence multiple disease processes through carefully designed molecules. The goal is to bring new cancer treatments and other therapies to patients by advancing its degrader-based drugs through research, collaboration, and development toward commercial use.

Company size
201-500
Company stage
IPO
Headquarters
Brisbane, CA
Founded
2012

Recently Posted Jobs

Explore more opportunities at Nurix Therapeutics

See more jobs